Reduced intestinal GLP-1 + cell numbers are associated with an inflammation-related epithelial metabolic signature
Preprint
Abstract
Background & Aims: Enteroendocrine cells (EECs) are known for their role in digestion and metabolism, yet their role in intestinal inflammation remains unclear. In inflammatory bowel diseases (IBD), a contribution of EECs to pathogenesis is indicated by autoantibodies affecting EEC function and general disease symptoms like insulin resistance and altered intestinal motility. Particularly, the L cell-derived hormone glucagon-like peptide 1 (GLP-1), suggested to orchestrate metabolic-inflammatory responses may influence inflammatory pathways in the intestine. Methods: We quantified numbers of GLP-1 + cells in 4 different mouse models of intestinal inflammation and performed transcriptional analyses of colonic epithelial cells from inflamed interleukin (IL)10-deficient mice. Using a publicly available single-cell RNA sequencing dataset including mucosal biopsies from Crohn’s disease (CD) patients, we confirmed findings from the murine models. A model of mitochondrial dysfunction (ClpP ΔIEC mice) as well as murine and human intestinal organoids were used to study molecular mechanisms. Results: Numbers of GLP-1 expressing cells are consistently reduced at the site of active disease in mouse models and CD patients. Despite this reduction, L cells from inflamed IL-10-deficient mice remained functional regarding GLP-1 secretion. Transcriptional analyses of intestinal epithelial cells indicate altered differentiation correlating with an inflammatory metabolic fingerprint. Reduced GLP-1 + cells in ClpP ΔIEC mice and inhibition of respiration in organoid cultures supports a causative role for metabolism in steering differentiation. Conclusion: Reduction of GLP-1 + cells represents a general feature of ileal and colonic inflammation in mice and human. Given the numerous properties of GLP-1, this reduction likely affects inflammatory processes in the mucosa and disease-related symptoms on multiple levels, and therefore, should be considered a therapeutic target in IBD. Data Transparency: All data generated or analyzed during this study are included in this published article. Additional datasets, including raw data, are available from the corresponding author upon reasonable request. Synopsis: This study examines GLP-1 + cells in intestinal inflammation, showing consistent reductions in inflamed areas. Findings from mouse models and human data reveal an inflammatory metabolic profile linked to altered epithelial differentiation. GLP-1, involved in endocrine-immune crosstalk, may impact mucosal inflammation and symptoms, making it a therapeutic target. GraphicalKeywords
All Related Versions
- Published version: Cellular and Molecular Gastroenterology and Hepatology, 20 (2), 101656.
This publication has 105 references indexed in Scilit:
- Colonic inflammation induces changes in glucose levels through modulation of incretin systemPharmacological Reports, 2021
- Expression of serotonin receptor HTR4 in glucagon-like peptide-1-positive enteroendocrine cells of the murine intestinePflügers Archiv - European Journal of Physiology, 2020
- Diversity of enteroendocrine cells investigated at cellular and subcellular levels: the need for a new classification schemeHistochemistry and Cell Biology, 2018
- Mitochondria at the Interface Between Danger Signaling and Metabolism: Role of Unfolded Protein Responses in Chronic InflammationInflammatory Bowel Diseases, 2012
- T Cell Transfer Model of Colitis: A Great Tool to Assess the Contribution of T Cells in Chronic Intestinal Inflammation2011
- Teduglutide, a novel mucosally active analog of glucagon-like peptide-2 (GLP-2) for the treatment of moderate to severe Crohnʼs diseaseInflammatory Bowel Diseases, 2010
- Glucagon-like peptide-1 receptor signalling selectively regulates murine lymphocyte proliferation and maintenance of peripheral regulatory T cellsDiabetologia, 2010
- PepT1 oligopeptide transporter (SLC15A1) gene polymorphism in inflammatory bowel diseaseInflammatory Bowel Diseases, 2009
- Autoantibodies against ubiquitination factor E4A (UBE4A) are associated with severity of Crohnʼs diseaseInflammatory Bowel Diseases, 2008
- Bacteria- and host-derived mechanisms to control intestinal epithelial cell homeostasis: Implications for chronic inflammationInflammatory Bowel Diseases, 2007